CHI Advisors LLC 13F Holdings · last filed Q3 2023
CHI Advisors LLC reported 26 securities worth $252.31M in its SEC 13F filing for Q3 2023 (period ended 2023-09-30). Top holdings: PLRX (20.74%), RPTX (14.27%), CGEM (12.25%). Among its top 25 positions this quarter: 4 new, 9 added, 6 trimmed.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | PLRX | PLIANT THERAPEUTICS INC | $52.3M | 20.74% | 3.2M | Trimmed |
| 2 | RPTX | REPARE THERAPEUTICS INC | $36.0M | 14.27% | 3.0M | Added |
| 3 | CGEM | CULLINAN ONCOLOGY INC | $30.9M | 12.25% | 3.4M | Hold |
| 4 | SLRN | ACELYRIN INC | $23.0M | 9.12% | 2.3M | Trimmed |
| 5 | ORTX | ORCHARD THERAPEUTICS PLC | $14.0M | 5.56% | 12.3M | Added |
| 6 | LRMR | LARIMAR THERAPEUTICS INC | $13.5M | 5.35% | 3.4M | Hold |
| 7 | KROS | KEROS THERAPEUTICS INC | $13.0M | 5.15% | 407,633 | Added |
| 8 | IKNA | IKENA ONCOLOGY INC | $9.4M | 3.74% | 2.2M | Added |
| 9 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $7.7M | 3.04% | 215,000 | Added |
| 10 | CMPX | COMPASS THERAPEUTICS INC | $5.6M | 2.21% | 2.8M | Hold |
| 11 | MLYS | MINERALYS THERAPEUTICS INC | $5.4M | 2.14% | 568,379 | New |
| 12 | INZY | INOZYME PHARMA INC | $5.3M | 2.11% | 1.3M | Added |
| 13 | SYRS | SYROS PHARMACEUTICALS INC | $5.1M | 2.03% | 1.3M | Added |
| 14 | BPMC | BLUEPRINT MEDICINES CORP | $4.7M | 1.85% | 92,888 | New |
| 15 | LABD | DIREXION SHS ETF TR | $4.6M | 1.84% | 225,000 | Trimmed |
| 16 | TSVT | 2SEVENTY BIO INC | $3.9M | 1.56% | 1.0M | Added |
| 17 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $3.4M | 1.36% | 60,000 | New |
| 18 | OVID | OVID THERAPEUTICS INC | $3.3M | 1.32% | 864,822 | Hold |
| 19 | SGMT | SAGIMET BIOSCIENCES INC | $3.1M | 1.22% | 348,842 | New |
| 20 | OMGA | OMEGA THERAPEUTICS INC | $2.3M | 0.90% | 1.1M | Hold |
| 21 | BDTX | BLACK DIAMOND THERAPEUTICS I | $2.1M | 0.82% | 720,000 | Trimmed |
| 22 | RLYB | RALLYBIO CORP | $1.3M | 0.52% | 390,734 | Trimmed |
| 23 | IRON | DISC MEDICINE INC | $1.2M | 0.47% | 25,000 | Trimmed |
| 24 | LENZ | GRAPHITE BIO INC | $572,726 | 0.23% | 230,938 | Hold |
| 25 | BRLT | FREELINE THERAPEUTICS HLDGS | $372,613 | 0.15% | 86,654 | Added |
Source: SEC Form 13F filings · as of 2023-09-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR